![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, ... Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York. Show more
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Companyโs โPulse-Primeโ hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection...
Latest data from first and second cohorts support Companyโs 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at...
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection...
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -4.3956043956 | 2.73 | 2.73 | 2.34 | 27293 | 2.53826512 | CS |
4 | 0.3 | 12.987012987 | 2.31 | 3.1 | 2.29 | 44076 | 2.62757766 | CS |
12 | 0.14 | 5.66801619433 | 2.47 | 3.1 | 1.9719 | 29360 | 2.5601518 | CS |
26 | 0.64 | 32.4873096447 | 1.97 | 3.1 | 1.57 | 53411 | 2.33268863 | CS |
52 | 0.6 | 29.8507462687 | 2.01 | 4.08 | 1.57 | 35254 | 2.36819719 | CS |
156 | -7.49 | -74.1584158416 | 10.1 | 28.8299 | 1.25 | 444956 | 9.2857626 | CS |
260 | -7.49 | -74.1584158416 | 10.1 | 28.8299 | 1.25 | 444956 | 9.2857626 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions